
Urisped 0.4 Tablet MR
Marketer
Accilex Nutricorp
Salt Composition
Tamsulosin (0.4mg)
Overview Urisped 0.4 Tablet MR
Alfuzosin 0.4mg modified-release tablets are alpha-1 blockers indicated for benign prostatic hyperplasia (BPH) symptom relief. This medication eases urinary difficulties but doesn't shrink the prostate. Follow your physician's prescribed dosage and schedule precisely. It can be taken with or without food, but consistently at the same time daily. Swallow the tablet whole; do not crush or chew. Discontinuing treatment prematurely may worsen symptoms, so complete the prescribed course for optimal results. Common side effects include dizziness, backache, chest discomfort, ejaculatory dysfunction, and retrograde ejaculation. Report any persistent or bothersome side effects immediately to your doctor. Lifestyle modifications, such as prompt urination when the urge arises (without straining), and limiting evening and pre-sleep consumption of caffeine and alcohol, can aid symptom management. Always disclose other medications you are taking to your doctor before starting this treatment. Inform your ophthalmologist about Alfuzosin use if undergoing cataract or glaucoma surgery. Individuals with liver impairment require close monitoring and regular follow-up appointments as directed by their physician.
Primary Ingredients of Urisped 0.4 Tablet MR
No text was provided to rewrite.
Uses of Urisped 0.4 Tablet MR
Managing benign prostatic enlargement
Major Benefits of Urisped 0.4 Tablet MR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Urisped 0.4 Tablet MR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While this medication can be administered with or without food, consistency in timing is recommended.
Common Side effects of Urisped 0.4 Tablet MR:
- Chest pain
- Inflammation of the nose
- Dizziness
- Ejaculation disorder
- Headache
- Abdominal pain
- Back pain
- Nausea
- Infection
How to use Urisped 0.4 Tablet MR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Urisped 0.4 MR tablets can be consumed with or without food, although consistent timing is recommended.
How Urisped 0.4 Tablet MR works:
Urisped 0.4 MR tablets contain an alpha-adrenergic blocking agent. By relaxing bladder neck and prostate muscles, they facilitate easier urination. This improves bladder emptying and lessens the frequency and urgency of urination associated with benign prostatic hyperplasia (BPH).
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Urisped 0.4 MR tablets and alcohol may induce pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Urisped 0.4 MR tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
The use of Urisped 0.4 MR tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Urisped 0.4 MR tablets are contraindicated in lactating women.
DrivingSAFE
Driving ability is typically unaffected by Urisped 0.4 MR tablets.
KidneySAFE IF PRESCRIBED
Urisped 0.4 MR tablets can be safely administered to individuals with kidney impairment without requiring dosage modification. Nevertheless, data regarding its use in patients with terminal kidney failure is scarce. Physician consultation is advised.
LiverCAUTION
Patients with significant hepatic impairment should exercise caution when using Urisped 0.4 mg modified-release tablets. Dosage modification of Urisped 0.4 mg modified-release tablets may be necessary; physician consultation is advised.
What if you forget to take Urisped 0.4 Tablet MR :
Should you forget to take a Urisped 0.4 MR Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Urisped 0.4 Tablet MR
| Label | Value |
|---|---|
| Chemical Category | Sulfonamide-based compound |
| Developing Habits | No. |
| Treatment Category | Urology |
